Peptide aptamers: recent developments for cancer therapy
Author:
Publisher
Informa Healthcare
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology
Link
http://www.tandfonline.com/doi/pdf/10.1517/14712598.5.6.783
Reference118 articles.
1. Reversibility of oncogene-induced cancer
2. Conditional animal models: a strategy to define when oncogenes will be effective targets to treat cancer
3. Transient excess of MYC activity can elicit genomic instability and tumorigenesis
4. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes
5. Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeted Delivery Methods for Anticancer Drugs;Cancers;2022-01-26
2. Report on biopharmaceutical profile of recent biotherapeutics and insilco docking studies on target bindings of known aptamer biotherapeutics;Biotechnology and Genetic Engineering Reviews;2020-07-02
3. Advancing Aptamers as Molecular Probes for Cancer Theranostic Applications—The Role of Molecular Dynamics Simulation;Biotechnology Journal;2020-01-07
4. Peptide Therapeutics and the Pharmaceutical Industry: Barriers Encountered Translating from the Laboratory to Patients;Current Medicinal Chemistry;2016-12-05
5. Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides;Oncotarget;2016-03-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3